News

The company has received approval from Central Drugs Standard Control Organisation

The company is the first company in India to receive this regulatory nod for Suvorexant

The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% control of the target entity

Pimavanserin, marketed globally as NUPLAZID, has become a preferred treatment in the US antipsychotic segment

The brand Magtein by Threotech LLC has a sales value of around $438 million

This is in addition to 15 molecules for which the company entered the contract with UK/EU based clients on February 27, 2024

The API Manufacturing Site has already received approval from USFDA and EU

Based on the outcome of these trials, the supplies will be done from the company’s FDA approved manufacturing facility situated at Savli, Vadodara

BHL will undertake the development and supply of these molecules, which will be exclusively manufactured for its clientele

With the commissioning of this plant, the company has expanded the capacity almost three times

This Plant is the biggest Manufacturing plant of Alkaloids from Concentrated Poppy Straw in India

The receipt of the Establishment Inspection Report signifies the successful conclusion of the inspection

The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications

USFDA has conducted pre- approval inspection of its API facility from November 14, 2022 to November 17, 2022

The company plans to execute both these tenders at their API manufacturing unit located at Savli, Gujarat, India